SEC Form 4 · accession 0000914190-15-000295
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Marcel Veronneau
Officer — SVP - Clinical Controls
Period of report
Aug 7, 2015
Accepted (ET)
Aug 11, 2015 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 34,913 | D | ||
| Common Stock | holding | — | — | — | 6,827 | I | by Stock Bonus Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $108.49 | Aug 7, 2015 | A | 7,500 | A | — | Aug 7, 2022 | Common Stock | 7,500 | 7,500 | D |
| Stock Option (Right to Buy)F6 | $108.49 | Aug 7, 2015 | A | 3,750 | A | — | Aug 7, 2022 | Common Stock | 3,750 | 3,750 | D |
| Restricted Stock UnitsF5,F6 | — | Aug 7, 2015 | A | 600 | A | — | — | Common Stock | 600 | 600 | D |
| Stock Option (Right to Buy)F1 | $62.46 | holding | — | — | — | — | Jul 23, 2016 | Common Stock | 494 | 494 | D |
| Stock Option (Right to Buy)F1 | $66.25 | holding | — | — | — | — | Apr 29, 2017 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F1 | $58.40 | holding | — | — | — | — | Jul 29, 2017 | Common Stock | 1,281 | 1,281 | D |
| Stock Option (Right to Buy)F1 | $76.15 | holding | — | — | — | — | Jul 27, 2018 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (Right to Buy)F1 | $76.15 | holding | — | — | — | — | Aug 27, 2018 | Common Stock | 1,129 | 1,129 | D |
| Stock Option (Right to Buy)F1 | $74.05 | holding | — | — | — | — | Jul 26, 2019 | Common Stock | 1,097 | 1,097 | D |
| Stock Option (Right to Buy)F2 | $76.02 | holding | — | — | — | — | Jul 31, 2020 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (Right to Buy)F3 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Fully exercisable.
- F2Vests 3,750 shares on each of 8/1/14, 8/1/15, 8/1/16, and 8/1/17.
- F3Vests 3,750 shares on each of 8/12/15, 8/12/16, 8/12/17, and 8/12/18.
- F4Vests 1,875 shares on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- F5Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F6Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.